Search results
VBI-1901 shows promise in glioblastoma interim study By Investing.com
Investing.com· 7 days agoVBI Vaccines Inc. (NASDAQ:VBIV), a biopharmaceutical company, revealed interim data from a Phase 2b...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 7 days agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Burkina Faso named most neglected crisis for second year in a row
KOAM· 1 day agoIn its annual report, released Monday, the NRC said the West African country saw a record-high 707,000 new displacements in 2023, driven by escalating violence and a worsening humanitarian crisis ...
The problems with the middle class and ketamine therapy
Market Watch· 3 days agoToday, Venessa comes on the show and explains why the inflation shock of recent years put the final...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 21 hours agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively ...
GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive via Yahoo Finance· 3 days agoStudy results showed the antibody-drug conjugate helped stave off disease progression better than a...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 5 days agoSummit Therapeutics Inc. investors sent the company's stock up 272% Thursday following the release...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial...
KOLR - KSFX Ozarks· 4 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC ...
FDA delays decision on Dupixent in COPD; Summit makes a bold claim
BioPharma Dive via Yahoo Finance· 5 days agoRegeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...
Skadden lawyer with ALS is focus of Amazon Prime documentary
Reuters· 2 days agoIt started in 2017, when Brian Wallach casually mentioned to his doctor that his left hand had been...